NFATC2 in pancreatic cancer-associated fibroblasts predicts treatment response and facilitates ERBB-targeted therapies
JIAHAO GUO, Samuele Cancellieri, Chi Xu, Celina Wiik, Liangru Fei, Shiva Dahal‐Koirala, Emma Maria Haapaniemi, Tero A. Aittokallio, Caroline Sophie Verbeke, Biswajyoti Sahu
The paper identifies NFATC2-expressing cancer-associated fibroblasts in PDAC that improve treatment response and enhance ERBB-targeted therapies.
bioRxiv · Apr 8, 2026 · PreprintCancer Biology